International Biotechnology (LON:IBT) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened

International Biotechnology (LON:IBT) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 959.39 and traded as high as GBX 1,214.25. International Biotechnology shares last traded at GBX 1,205, with a volume of 151,650 shares traded.

International Biotechnology Trading Up 2.5%

The firm has a market cap of £393.08 million, a P/E ratio of 5.11 and a beta of 0.52. The company has a debt-to-equity ratio of 9.43, a quick ratio of 0.32 and a current ratio of 0.11. The firm has a 50 day simple moving average of GBX 1,001.69 and a 200 day simple moving average of GBX 959.39.

International Biotechnology (LON:IBT) last released its quarterly earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. The firm had revenue of GBX 24 million for the quarter. On average, equities research analysts predict that International Biotechnology will post 0.9435943 EPS for the current fiscal year.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.